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Background. Research on mood disorders has progressively focused on the study of seasons and on the mood in association with
them during depressive or manic episodes yet few studies have focused on the seasonal ﬂuctuation that characterizes the patient’s
clinical course both during an illness episode and during euthymic periods. Methods. 113 euthymic outpatients 46 aﬀected by
major recurrent depression and 67 aﬀected by bipolar disorder were recruited. We evaluated the impact of clinical “rhythmical”
factors: seasonality, sleep disturbance, and chronotype. Patients completed the SPAQ+ questionnaire, the MEQ questionnaire,
and the medical outcomes study (MOS) sleep scale. We used t-test analyses to compare diﬀerences of clinical “rhythmical” and
sociodemographic variables and of diﬀerences in the assessment scales among the diagnostic groups. Results. Patients reporting a
familyhistoryformooddisordershavehigherﬂuctuationsthroughoutseasons.Sleepdisturbanceismoreproblematicinunipolars
whencomparedtobipolars.Conclusions.Sleep,light,andseasonalityseemtobethreeinterconnectedfeaturesthatlieatthebasisof
chronobiology that, when altered, have an important eﬀect both on the psychopathology and on the treatment of mood disorders.
1.Introduction
The degree to which seasonal changes aﬀect mood is known
as seasonality. The periodical pattern of recurrence is a
biological feature of mood disorders, and the recovery from
the ﬁrst episode of illness is followed by a subsequent
recurrence in about 90% of aﬀected patients during their
lifetime [1]. In addition, the occurrence of diurnal variations
in mood and of distressful and pervasive disruption in sleep
suggests a primary disturbance of biological rhythms for
mood disorders [2].
The typical pattern of recurrence of mood disorder
followsinterindividualrules,sinceeachpatientpresentstheir
own speciﬁc pattern with a few episodes during their life,
or more than four episodes each year (rapid cycler). Some
authors have stressed the concept of seasonality, as many
patients show critical months of the year when they tend
to have a new recurrence independent of polarity [3]. The
recurrence pattern is also aﬀected by external factors, such as
exposition to light which appears to have an antidepressant
eﬀect both on its own and when associated to acute phar-
macological treatments, which shorten the subsequent cycle
of illness [4] and maintenance treatments, which are
expected to decrease the episode rates. Mood stabilizers, the
ﬁrst choice of treatment for bipolar disorder, can successfully
sustaintheeﬀectofchronotherapeuticsandcanhelptoman-
age the low risk of manic switches [5]. Chronotherapeutic
treatments such as sleep deprivation have been successfully
associated with antidepressant drugs with a serotonergic
[6–8] noradrenergic [9], mixed serotonergic-noradrenergic
[10–12], and dopaminergic [13] mechanism of action. In a
similar way, light therapy has been shown to hasten response
toserotonergicantidepressantsinnonseasonaldepression[8,
14]. Therefore, an environmental regulator of fundamental
importanceonbiorhythmsinlivingorganismsisrepresented
by the photoperiod, which is the variability of hours of light
throughout seasons. The disruption of circadian rhythms,
including an abnormal response to sunlight, have a role2 Depression Research and Treatment
in the pathophysiology of mood disorders; consequently,
both climate and latitude may inﬂuence seasonality [15].
On the extreme end of the spectrum, such as with seasonal
aﬀective disorder (SAD), the change of symptoms with
the seasons is associated with signiﬁcant dysfunction. Yet,
even patients with mood disorders not formally diagnosed
as SAD can show seasonal worsening of their symptoms
[16] meaning that seasonality can be considered as a
continuum.
Whatisthenatureofsleepdisordersinmajordepression?
It has been hypothesized that the circadian type, in other
words, a person’s chronotype, may have a role in seasonal
susceptibility in morningness and eveningness types [17];
morningness types maintain a more regular sleep-wake
cycle and prefer to carry out its activities during the day
time, while eveningness types have a more ﬂexible sleep-
wake cycle and are more active in the evening hours.
Natale et al. (2005) found that evening types seem to
feel better in summer (long photoperiod) than in other
seasons, while morning types seem to feel better in winter
(short photoperiod) [18]. It can be hypothesized therefore
that the duration of the photoperiod and its variations
throughout the seasons may inﬂuence the relapse or the
reoccurrenceofanillnessepisodeonthebasisofthesubject’s
chronotype. Furthermore, Perlman and colleagues (2006)
found that a persistent sleep deﬁcit after recovery (at least
partially) from a mood episode in Bipolar patients predicted
depressive symptoms during a six month follow-up period
[19].
1.1. Genetic Factors. Various twin studies suggest that there
is a genetic component behind susceptibility to seasonal
changes. A large study involving 4,638 adult twin pairs from
Australia found that genetic factors accounted for 29% of
the variance in seasonality. They also found that in each
behavioral domain, (i.e., mood, energy, social activity, sleep,
appetite, and weight), there is a signiﬁcant genetic inﬂuence
on the reporting of seasonal changes [20]. Another twin
studyinvolving339twinpairs[21]foundthatgeneticfactors
accounted 45.5% in males and 30.5% in females of the
variance for seasonality.
2.AIM
The purpose of this clinical study was to evaluate the
eﬀect of clinical “rhythmical” factors such as seasonality,
sleep disturbance, and chronotype, which can have an in-
ﬂuence on the course of the patient’s illness during a
period of euthymia. We obtained information on their
seasonal and sleep disturbances during a period of euthymia
and compared these variables between unipolars versus
bipolars. We compared patients with or without family
history of mood disorders for the variable “seasonality”,
we compared morningness and eveningness chronotypes to
assessdiﬀerences in sleepquality and atlast,we evaluatedthe
eﬀect of a lithium maintenance therapy on chronobiological
parameters comparing the patients with or without lithium
salts.
3. Methods
3.1. Participants. The sample in this cross-sectional longi-
tudinal study included 113 outpatients (80 females and 33
males): 46 aﬀected by major depressive disorder (unipolars)
and67aﬀectedbybipolardisorder.Thesamplewasrecruited
during the patients checkups at the outpatient Mood Dis-
order Unit of the San Raﬀaele Hospital in Milan, from
January, 2009 to March, 2010. Inclusion criteria were (1)
bipolarorunipolardisorderdiagnosisaccordingtoDSM-IV-
TRcriteria,(2)euthymicpatientswhichhadanormalranged
mood, without a depressed or elated mood for a period of
at least 24 months as measured by the hamilton depression
ratingscale(HDRS)<8ortheyoungmaniaratingscalescore
= 0, and (3) lithium or antidepressant (SSRIs) maintenance
therapy, according to the polarity of the forms and clinical
judgment. The lithium dosage was given on the basis of
the tested plasma level between 0.5 and 0.7mmol/L. Table 1
summarizes the clinical and demographic characteristics of
the sample. This study has been approved by the local
sanctioning board (ASL, Citt` a di Milano), and it meets
ethical standards.
3.2. Measures. The protocol for data collection consisted of
an anamnestic sheet ﬁlled out by the psychiatrist during the
patient’s checkup, and in a series of self-administered ques-
tionnaires: seasonal pattern assessment questionnaire (SPAQ),
morningness eveningness questionnaire (MEQ), and medical
outcomes study (MOS) sleep scale.
In the anamnestic sheet, the following data was collected:
age, sex, the polarity of the mood disorder, other Axis II and
IIIdiagnoses(accordingtotheDSMIV-TR),theageofonset,
total of number episodes, the recurrence index (number of
previous episodes/duration of illness), years of education,
family history of mood disorders, the current therapy, and
the duration of euthymia duration of maintenance therapy.
Most bipolar patients were on a monotherapy long-term
treatment with lithium salts.
3.2.1. Seasonal Pattern Assessment Questionnaire (SPAQ+).
The SPAQ+ (Italian version, [22]) is a self-administered
questionnaire which quantiﬁes (regardless of the presence or
absence of a psychiatric disorder), the individual’s tendency
to seasonal mood and behavioral changes, and this is
deﬁned as “seasonality.” The SPAQ [23]i n v e s t i g a t e ss e v e r a l
areas including demographic data, seasonal changes in sleep
length, social activity, mood, weight, appetite, and energy
level (Likert scales scored 0–4, used to calculate the global
seasonality score or GSS, with a total score ranging from 0–
24).
3.2.2.Morningness-EveningnessQuestionnaire(MEQ). Morn-
ingness types are those people who consistently prefer
diurnalactivity,whileeveningnesstypesarethosewhoprefer
nocturnal activities. The morningness/eveningness dimen-
sion is regulated by a complex interaction among social, geo-
graphic, and genetic factors. The morningness/eveningness
questionnaire [24] is the most commonly used self-reportDepression Research and Treatment 3
Table 1: Demographic and clinical characteristics of the sample.
Tot. n = 113
Unipolar Bipolar
N = 46 N = 67
mean ± SD mean ± SD
Age 54.98 ±11.88 51.32 ±13.20
Education years 11.83 ±4.24 12.05 ±4.31
Age of onset 34.00 ±14.44 31.72 ±13.47
Duration of Illness (years) 20.98 ±12.88 18.98 ±12.15
Total no. of episodes 5.39 ±4.86 8.36 ±7.91
Depressive episodes 5.21 ±4.35 5.20 ±5.32
Manic episodes /4 .63 ±12.45
Duration of euthymia (months) 29.93 ±37.19 30.57 ±35.60
Duration of maintenance
Therapy (months)
40.36 ±50.91 54.51 ±48.84
questionnaire for the assessment of preferred timing of
complexbehaviorsregardingsleep-wakehabitsandrhythms.
The questionnaire is normally distributed [25], and this
allowsustoconsiderthecircadiantypesasacontinuum[26].
The Italian version of the MEQ [27] includes 19 items, and
the sum yields a global score, ranging from 16 to 86 with
lowerscoresindicatinggreatereveningtendenciesandhigher
scores indicating greater morningness tendencies.
3.2.3. Medical Outcomes Study (MOS) Sleep Scale. The MOS
[28] is a self-administered instrument which consists of 12
items which measure six important dimensions of sleep,
including initiation (time to fall asleep), sleep disturbance
(have trouble falling asleep, how long to fall asleep, sleep was
notquiet,awakeningsduringsleepandhavingtroublefalling
back to sleep), quantity (hours of sleep each night), mainte-
nance, respiratory problems, perceived sleep adequacy (get
enough sleep to feel rested upon in the morning, getting
the needed amount of sleep), and day-time somnolence
(drowsiness during the day, nap taking). Answers were based
on a retrospective assessment over the past 4 weeks.
3.3. Statistical Analysis. A descriptive statistics of the sample
was carried out using SOFTSTA 6.0. In accordance with
diagnosis, gender, chronotype, family history, maintenance
t h e r a p yn o np a i r e dS t u d e n t ’ st-tests were carried out for the
sociodemographic, clinical variables, and rating scale scores
(Table 1).
4. Results
We then performed a t-test analysis to compare the two
diﬀerent disorders, unipolar and bipolar patients, and found
a signiﬁcant diﬀerence for greater sleep disturbance in
unipolar patients (t =− 2.27; P = 0.003). There is a
signiﬁcant diﬀerence also in the recurrence index, with a
higher recurrence in bipolar patients (t =− 0.55; P>0.000)
(Table 2).
We performed a t-test analysis between patients that
reported a family history for mood disorders, and we found
signiﬁcant diﬀerence in the following variables: age of onset
(t = 3.74; P<0.000) which is lower in individuals with a
family history, duration of illness (t =− 3.25; P<0.001)
which is longer for patients with a family history, number of
depressive episodes (t =− 2.66; P = 0.009) and total number
of episodes (t =− 2.58; P = 0.011), which are higher for
patients with a positive family history and GSS (t =− 2.13;
P = 0.035) which is higher for patients with a positive family
history (Table 3).
We decided to analyze if lithium salts (the maintenance
therapy considered a gold standard in the treatment of
bipolar disorders) when compared to other therapies, has an
eﬀect on the variables analyzed earlier as its eﬀects on sleep
quality have not previously been taken into consideration in
literature. In our sample of unipolar and bipolar patients,
we performed a t-test analysis between patients that take
lithium in their maintenance therapy for at least 6 months
versuspatients thatdo not. There weresigniﬁcant diﬀerences
for sleep disturbance (t = 3.03; P = 0.003), shortness of
breath (t = 3.83; P<0.000), sleep adequacy (t = 3.63;
P<0.000), and a notable even if not signiﬁcant diﬀerence
in sleep somnolence (t = 1.79; P = 0.060) indicating that
these sleep quality parameters better in those patients that
use lithium salts as a maintenance therapy (Table 4).
We also divided subjects according to their chronotype
to verify if being a morningness versus eveningness type
would inﬂuence our variables. The chronotype division was
performed using the subjects’ MEQ scores. We performed
a t-test analysis dividing MEQ according to categories of
chronotype into greater “morningness” (>59) and greater
“eveningness” (<41) and intermediate (>41 and <59) [26].
Patients highlighted a signiﬁcant diﬀerence in sleep distur-
bance (t = 2.52; P = 0.010) with morningness types
reporting a lower sleep disturbance and a better sleep
adequacy (t = 2.53; P = 0.013) (Table 5).
5. Discussion
Seasonalityseemstohaveatiewithafamilyhistoryformood
disorders: patients (both unipolar and bipolar) reporting a
positive family history for their disorder have a signiﬁcantly
higher seasonality, indicating that there might be a genetic
component that inﬂuences the amount of mood, energy,
appetite and sleep ﬂuctuation throughout seasons. This data
is consistent with the ﬁndings of Jang et al. [21]w h o
found that a genetic factors accounted for 45.5% (males)
and 30.5% (females) of the variance. Future genetic studies
on the heritability of seasonality could support further
conﬁrmations of these ﬁndings.
Patients that take lithium salts as a maintenance therapy
have a lower sleep disturbance, a lower shortness of breath, a
better sleep adequacy and an overall improved sleep quality.
This may suggest that lithium salts aid in stabilizing not
only mood ﬂuctuations themselves, but also help to regulate
all the rhythmical parameters such as sleep rhythms, which
are directly involved with the pathophysiology of mood4 Depression Research and Treatment
Table 2: t-test analysis between unipolar and bipolar patients.
Unipolars (N = 46) Bipolars (N = 67) t value P
Mean ± SD Mean ± SD
Total Number of episodes 5.39 ±4.86 8.36 ±7.91 −2.27 0.025
Duration of maintenance therapy (months) 40.36 ±50.91 54.51 ±48.83 −1.25 0.214
Episodes during maintenance therapy 0.26 ±0.77 0.68 ±1.50 −1.67 0.097
GSS 8.39 ±4.88 8.22 ±4.65 0.18 0.854
Sleep disturbance 37.39 ±25.04 24.32 ±20.40 3.01 0.003
Snoring 38.67 ±29.05 48.91 ±39.96 −1.47 0.145
S h o r to fb r e a t h 1 9 .57 ±24.03 14.38 ±23.49 1.13 0.260
Sleep adequacy 36.00 ±26.26 27.34 ±27.62 1.65 0.101
Sleep somnolence 31.39 ±20.54 38.59 ±27.80 −1.49 0.139
Sleep hours 7.26 ±1.73 7.41 ±1.36 −0.52 0.604
Recurrence index 2.87 ±2.95 4.36 ±2.99 −0.55 0.010
Table 3: t-test analysis between unipolar and bipolar patients that have a family have a family history for mood disorders versus those that
do not.
No family history (N = 34) Family history (N = 78) t value P
Mean ± SD Mean ± SD
Age 53.18 ±14.39 52.46 ±12.03 0.27 0.786
Education 11.21 ±4.40 12.37 ±4.14 −1.34 0.181
Age of onset 39.79 ±14.82 30.18 ±11.36 3.74 0.000
Duration of illness (years) 14.15 ±8.26 22.14 ±13.23 −3.25 0.002
Number of depressive episodes 3.35 ±2.21 6.00 ±5.48 −0.34 0.009
Number of manic episodes 1.29 ±1.49 3.33 ±11.75 −2.66 0.319
Total number of episodes 4.59 ±3.13 8.19 ±7.83 −1.00 0.011
Duration of maintenance therapy (months) 53.73 ±52.33 48.23 ±49.06 −2.58 0.636
GSS 6.85 ±4.16 8.90 ±4.87 −2.13 0.035
disorders. This could be a possible explanation to the fact
that unipolar patients reported more sleep problems, as the
majority of them do not take lithium Salts (38 do not take
it out of 46) as opposed to most bipolar patients who do
(50 take it out of 57) In a previous study, our group [13],
discussed the beneﬁts of lithium salts on sleep. A possible
explanation is that lithium is known to delay circadian
rhythms in animals [29] and lengthen the period of the
sleep-wake cycle in humans [30], leading to a phase delay
of circadian rhythms both in normal subjects and in bipolar
patients [31]. Given the eﬀects of lithium on the rhythmicity
of brain neurotransmitter function [32] and recent ﬁndings
about the regulation of circadian rhythmicity in mammals
[33, 34], the chronobiological eﬀect of lithium has been
proposed to at least partially explain its clinical eﬀect [35,
36].
When we subdivided our patients according to chrono-
type, we found morningness patients to have a sleep rhythm
which is less disturbed and a more adequate sleep quality.
H¨ at¨ onen et al. [37] and Mansour et al. [38]h a v ef o u n d
that circadian-type preference for evening activities has been
shown in bipolar patients: eveningness seems to be related
to morbidity and especially to sleep and mood disorders
[39]. It has been hypothesized that mood disorders may
be more prevalent in individuals with a shifted clock. One
hypothesis is that clock genes have been shown to regulate
circadianbehaviourandpreference[40],sosleepandrhythm
performance may be a part of the phenotype correspond-
ing to these circadian clock shifts [41]. Another possible
explanation is that since exposure to outdoor light aﬀects
the phase of entrainment and our society has schedules
for the most part synchronised according to morningness
types, eveningness types pay the consequences in terms
of sleep loss and reduced sleep quality [42]. It has been
shown that repeated sleep restriction causes a cumulative
increase in daytime sleepiness and waking neurobehavioral
deﬁcits [43]. This is a relevant issue especially for mood
disordered patients, because altered sleep quality can be
one of the triggers for an illness episode. As it is widely
known, sleep loss is often a precursor and/or a precipitant of
hypomania or mania in bipolar patients. Knowing a patient’s
chronotypecanbeusefulinhelping thepatienttomaintaina
regular sleep hygiene to prevent sleep loss and consequently
a circadian rhythm deregulation.
We found, on the contrary to studies carried out by Shin
etal.(2005)whofoundthatindividualswithbipolardisorder
experience a higher seasonality variation, no diﬀerences
among diagnosis in seasonality scores [44]. This could beDepression Research and Treatment 5
Table 4: t-test analysis between unipolar and bipolar patients that are in maintenance therapy with lithium salts versus patients that are not.
No lithium Lithium
t value P (N = 38 unipolars, 17 bipolars) (N = 55) (N = 5 unipolars, 50 bipolars) (N = 55)
Mean ± SD Mean ± SD
Sleep disturbance 36.28 ±24.11 23.30 ±20.64 3.03 0.003
S h o r to fb r e a t h 2 4 .72 ±28.54 8.361 ±13.71 3.83 0.000
Sleep adequacy 39.93 ±27.81 22.00 ±23.76 3.63 0.000
Sleep somnolence 39.83 ±23.83 31.33 ±25.98 1.79 0.060
Table 5: t-test analysis between morningness and eveningness patients.
Eveningness types (N = 16) Morningness types (N = 67) t value P
Mean ± SD Mean ± SD
Sleep disturbance 40.17 ±28.07 25.61 ±18.71 2.52 0.010
S h o r to fb r e a t h 1 8 .75 ±17.08 17.42 ±27.22 0.19 0.853
Sleep adequacy 47.50 ±33.37 28.09 ±26.24 2.53 0.013
Sleep somnolence 48.58 ±28.873 35.33 ±25.46 1.83 0.071
due to the fact a large portion of our sample has a history
of maintenance therapy; unipolar subjects with a high
rate of depressive recurrences are treated with maintenance
therapy (mainly with SSRI), while bipolars are for the most
part on long-term lithium treatment, which, as mentioned
previously, may alter and reduce seasonal ﬂuctuations.
Limitations of our study include that the use of retro-
spective questionnaires (such as the SPAQ+) always raise
the possibility of recall bias. Furthermore, we have a lack of
information about the lighting conditions to which subjects
were exposed in their usual environment and the study
period was relatively short in length and multiple years
of data may be required to detect statistically signiﬁcant
seasonal eﬀects. Another major limitation of our study is
that we did not collect a control sample. Finally, as we
have seen, sleep, light, and seasonality seem to be three
interconnected features that lie at the basis of chronobiology
that, when altered, have an important eﬀect both on the
psychopathology and on the treatment depression. These
ﬁndings, paired with future acquisitions, will be useful
in the clinical practice, both for prevention and for the
manipulation of these features for a therapeutic aim.
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